Ohio State researchers develop novel anticancer peptide vaccines and inhibitors

[News]

Researchers have developed two new anticancer peptide vaccines and two peptide inhibitors as part of a larger peptide immunotherapy effort at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

More... (http://www.news-medical.net/news/20140925/Ohio-State-researchers-develop-novel-anticancer-peptide-vaccines-and-inhibitors.aspx)